SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Torrent Pharma registers 80% growth in Q4 net profit

21 May 2012 Evaluate

Torrent Pharmaceuticals has registered 80.09% jump in net profit at Rs 80.07 crore for the quarter ended March 31, 2012, compared with a profit of Rs 44.46 crore for the same quarter a year ago.

The company’s total income surged 34.13% to Rs 544.59 crore for the quarter under review as compared to Rs 406.03 crore for the corresponding quarter previous fiscal.

The PSU firm’s net profit for the full financial year 2011-12 rose 7.01% to Rs 311.25 crore in the year under review as against Rs 290.86 crore in FY11. However, total income increased by 18.51% to Rs 2076.04 crore for the year ended March 31, 2012 from Rs 1751.73 crore in FY11.   

Torrent Pharmaceuticals has recommended a final dividend of Rs 2.50 per equity share of Rs 5 each fully paid up.

Torrent Pharma Share Price

4765.60 103.00 (2.21%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: